Patents
Patents for C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
01/2008
01/31/2008US20080027229 Compounds for the treatment of metabolic disorders
01/31/2008US20080027226 Electroluminescent Device
01/31/2008US20080027117 Antifungal Azole Derivatives Having a Fluorovinyl Moiety and Process for the Preparation Thereof
01/31/2008US20080027060 Dipeptide nitriles
01/31/2008US20080027047 Compounds that modulate HSP90 activity and methods for identifying same
01/31/2008US20080025940 Administration of 3-sulfanylpropanamide compounds for stimulating hair and eyelash growth and/or for stopping the loss and/or limiting the depigmentation thereof
01/30/2008CN101115728A Triazole substituted aminobenzophenone compounds
01/30/2008CN101115717A Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
01/29/2008US7323480 Diseases mediated by Peroxisome Proliferator-Activated Receptors such as glucose metabolism, lipid metabolism and insulin secretion, specifically Type 2 diabetes, hyperinsulemia, hyperlipidemia, hyperuricemia, hypercholesteremia, atherosclerosis, risk factors for cardiovascular disease, Syndrome X
01/24/2008WO2007094819A3 Triazole compounds that modulate hsp90 activity
01/24/2008US20080021109 5-[3-(2,6-Dimethylbenzyloxy)-phenyl]-pent-4-enoic acid ethyl ester; insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis, arteriosclerosis; side effects reduction; orally active
01/24/2008US20080021080 4-(3-{[4-(4-Ethyl-3-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)phenyl]thio}phenyl)tetrahydro-2H-pyran-4-carboxamide (Compound No. 1); bronchial asthma, chronic obstructive pulmonary disorder, arthritis, type I diabetes, multiple sclerosis, allograft rejection, psoriasis, inflammatory bowel disease
01/24/2008US20080021011 Therapeutic compounds
01/24/2008CA2657776A1 Triazolyl phenyl benzenesulfonamides
01/23/2008EP1879873A1 Neurotherapeutic azole compounds
01/23/2008EP1879548A2 Process for coloring keratin fibers comprising metal complexes
01/23/2008CN100363352C 3-nitro-1,2,4-triazole-5-ketone superfining process
01/22/2008US7320994 {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chloro-phenyl)-methanone; anxiety, depression, psychosis, and schizophrenia and other psychotic disorders; neurodegenerative disorders, multiple sclerosis and amyotrophic lateral sclerosis
01/17/2008WO2008007211A1 Substituted n-bicyclicalkyl bicyclic carboxyamide compounds
01/17/2008WO2007019080A3 Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease
01/17/2008US20080015355 for use in electronic devices, especially organic light emitting diodes (OLEDs), as oxygen sensitive indicators, as phosphorescent indicators in bioassays, and as catalysts
01/17/2008US20080015209 Compounds for the treatment of metabolic disorders
01/17/2008US20080015199 Triazolone derivatives
01/17/2008US20080015193 Certain azoles exhibiting ATP-utilizing enzyme inhibitory activity, compositions, and uses thereof
01/17/2008US20080015157 Novel Water-Soluble Prodrugs
01/17/2008US20080014189 Diaminotriazoles useful as inhibitors of protein kinases
01/16/2008EP1877380A1 Sulfonylamino(thio)carbonyl compounds in the form of herbicides or plant growth regulators
01/16/2008EP1877365A1 Acetylene derivatives
01/16/2008EP1877364A1 Phenylacetylene derivatives having mglur5 receptor affinity
01/16/2008EP1501809B1 Triazole derivatives as tachykinin receptor antagonists
01/16/2008CN101107251A Bicyclic pyrimidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
01/16/2008CN101104607A Method for preparing high purity 1H-1,2,3-triazole
01/15/2008US7319110 1H-1,2,4-triazole-3-carboxamide derivatives having cannabinoid-CB1 receptor agonistic, partial agonistic, inverse agonistic or antagonistic activity
01/15/2008US7318966 Luminescent element material and luminescent element comprising the same
01/10/2008US20080009504 enzyme inhibitors of glucan synthase;1S,2R,3R,4aR,6aS,7R,8R,10aR,10bR,12aR)-3-(acetyloxy)-2-[(2S)-2-amino-2,3-dimethylbutyloxy]-8-[(1R)-1,2-dimethyl propyl]-1,6a,8,10a-tetramethyl-6-oxo-1,3,4,6,6a,7,8,9,10,10a,10b,11,12,12a-tetradecahydro-2H-1,4a-(methanooxymethano)chrysene-7-carboxylic acid
01/10/2008US20080009496 Mutagenic heterocycles
01/10/2008US20080008708 Tyrosine kinase inhibitors
01/09/2008EP1875240A2 The preparation of molecular imaging probes using click chemistry
01/09/2008EP1874740A1 Electroluminescent device
01/09/2008CN100360525C Novel oxazolidone derivative, its preparing method and use
01/08/2008US7317031 3-(SO2-substituted anilino)-5-amino-1-((hetero)aryl-carbonyl- or sulfonyl)-1H-1,2,4-triazoles: 4-[[5-amino-1-[(3-methyl-2-thienyl)carbonyl]-1H-1,2,4-triazol-3-yl]amino]-benzenesulfonamide; for treating melanoma; cervical, ovarian and prostate adenocarcinoma; colon carcinoma and breast cancer
01/08/2008US7317024 Obesity, diabetes, inflammatory and immune diseases
01/03/2008WO2008001195A2 Novel processes for the preparation of dpp iv inhibitors
01/03/2008US20080004331 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition
01/03/2008US20080004277 Triazole compounds that modulate HSP90 activity
01/03/2008US20080004275 Antiviral 4-Aminocarbonylamino-Substituted Imidazole Compounds
01/03/2008US20080004259 Anticancer agents; initiating mitosis which causes tumor cell death
01/02/2008EP1871752A1 Amidopropoxyphenyl orexin receptor antagonists
01/02/2008EP1871750A1 Improved process for the preparation of letrozole
01/02/2008EP1871749A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
01/02/2008CN101098844A Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
01/02/2008CN100358875C Fluoro-contained 1H-1,2,3-triazaazole compounds, preparation method thereof and their use
01/02/2008CN100358867C Heterocyclic inhibitors of glycogen synthase kinase GSK-3
01/01/2008USRE39991 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
01/01/2008US7314875 Tricyclic aromatic and bis-phenyl sulfinyl derivatives
12/2007
12/27/2007WO2007149448A2 Pyrazinones as cellular proliferation inhibitors
12/27/2007WO2007147311A1 2-substituted benzothiazo-1,2,4-triazolinone derivatives, the preparation methods and herbicidal effects thereof
12/27/2007WO2007047306A8 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors
12/27/2007WO2007047305A8 Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors
12/27/2007US20070299085 N1-((Pyrazol-1-Ymethyl)-2-Methylphenyl)-Phatalamide Derivatives And Related Compounds Insecticides
12/27/2007US20070299074 Guanidine Compounds, and Use Thereof as Binding partners for 5-Ht5 Receptors
12/27/2007US20070299064 Pesticidal Heterocyclic Dihaloallyl Compounds
12/27/2007US20070298507 Fluorescent Probe
12/27/2007CA2652859A1 Pyrazinones as cellular proliferation inhibitors
12/26/2007CN101094837A Novel beta agonists, method for producing the same and their use as drugs
12/26/2007CN101094830A Fused bicyclic carboxamide derivatives for use as CXCR2 inhibitors in the treatment of inflammation
12/26/2007CN100357278C Substituted triazole diamine derivatives as kinase inhibitors
12/26/2007CN100357277C 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
12/21/2007WO2007144896A1 A method of manufacture of letrozole
12/21/2007WO2007144174A1 Ethenyl carboxamide derivatives useful as microbiocides
12/21/2007CA2654097A1 Ethenyl carboxamide derivatives useful as microbiocides
12/20/2007US20070293555 4-methoxy-benzoic acid 1-imidazol-1-yl methyl-2-(4-fluorophenoxy)-ethyl ester; N-[(1-imidazol-1-yl methyl)-2-phenoxy-ethyl]-4-iodo-benzamide; cancer, inflammation, septic shock, infertility, preterm labor, pain, or an ischemia
12/20/2007US20070293540 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition
12/20/2007US20070293423 Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide
12/19/2007EP1032556B1 Pharmaceutically active compounds and methods of use
12/19/2007CN100355738C 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
12/18/2007US7309792 Dimeric small molecule potentiators of apoptosis
12/18/2007US7309721 Aminoalkylphosphonates and related compounds as Edg receptor agonists
12/13/2007WO2007141799A1 A process for preparing pure anastrozole
12/13/2007WO2007141009A1 N- (l-alkyl-2- phenylethyl) -carboxamide derivatives and use thereof as fungicides
12/13/2007US20070286997 Material Composition for Conductive Layers in Electronic Devices
12/13/2007CA2653520A1 N- (l-alkyl-2- phenylethyl) -carboxamide derivatives and use thereof as fungicides
12/12/2007EP1863777A1 1,2,4 -triazole-5-one compounds as heterocyclic reverse transcriptase inhibitors
12/12/2007EP1863484A1 Substituted triazole derivatives as oxytocin antagonists
12/12/2007CN101087755A Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
12/12/2007CN100354269C Substituted fluoralkoxyphenylsulfonylamino(thio)carbonyltriazolino(thi)ones
12/12/2007CN100354268C Novel triazolo pyrimidine compounds
12/11/2007US7307172 7-amino triazolopyrimidines for controlling harmful fungi
12/06/2007WO2007140233A1 Inhibitors of polo-like kinases
12/06/2007WO2007140174A2 Compounds and methods for modulating fxr
12/06/2007WO2007139968A2 Triazole compounds that modulate hsp90 activity
12/06/2007WO2007139955A2 Triazole compounds that modulate hsp90 activity
12/06/2007WO2007039919A8 Crystalline forms of anastrozole
12/06/2007US20070281982 crystallilzing anastrozole base, from an aqueous-based solvent containing water and a water soluble solvent selected from dimethyl formamide, dimethyl acetamide, c1-c4 alcohol, and dilute HCl, that contains anastrozol dissolved therein; pharmaceutically acceptable grade of purity
12/06/2007US20070281952 Arylsulfonylnaphthalene Derivatives As 5Ht2a Antagonists
12/06/2007CA2653332A1 Triazole compounds that modulate hsp90 activity
12/06/2007CA2653329A1 Triazole compounds that modulate hsp90 activity
12/06/2007CA2653222A1 Triazole compounds that modulate hsp90 activity
12/06/2007CA2651373A1 Compounds and methods for modulating fxr
12/06/2007CA2647592A1 Inhibitors of polo-like kinases
1 ... 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 ... 178